EUVIMEDEUVIMED entdecken
Crossref

Challenges in circulating miRNA analysis in adrenocortical tumors

Bálint Vékony iD, Gábor Nyirő, Henriett Butz, Bálint Kende Szeredás, Viktória Tóth, Peter Ferdinandy, Attila Patócs iD, Peter Igaz iD

Endocrine-Related Cancer · 2025

DOI: 10.1530/erc-25-0045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2025. Verfasst von Bálint Vékony und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Adrenal Cortex Neoplasms, Circulating MicroRNA, MicroRNAs, Biomarkers, Tumor. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The differentiation of benign and malignant adrenocortical tumors is of major clinical relevance. Circulating microRNAs (miRNAs) hold promise as blood-borne biomarkers of adrenocortical cancer (ACC). There are, however, many difficulties with their use, including technical and biological standardization challenges. Our aim was to evaluate the interchangeability of quantitative polymerase chain reaction (qPCR) and digital PCR (dPCR) for measuring circulating miRNAs and to investigate whether K2- and K3-EDTA as anticoagulants influence the measurements. Blood samples were drawn simultaneously from 20 participants into K2- and K3-EDTA tubes. Three miRNAs shown to be associated with ACC ( miR-483-5p , miR-210-3p, miR-21-5p ), together with two controls ( miR-16-5p, cel-miR-39-3p ), were analyzed using RT-qPCR and dPCR. qPCR and dPCR results showed different correlations in K2- and K3-EDTA samples, with K2 performing better regarding ΔCt values. Moreover, proportional biases related to low or high miRNA expressions between the two methods were observed. In qPCR measurements, K3-EDTA samples showed larger standard deviations, particularly for cel-miR-39 . While raw Ct values differed between K2- and K3-EDTA only for miR-483-5p , ΔCt values showed statistically significant differences across all miRNAs except for miR-483-5p . dPCR results were not affected by the choice of anticoagulant. In conclusion, this is the first study demonstrating that dPCR and qPCR results are not easily interchangeable for circulating miRNA, particularly for abundant or rare miRNAs, making cross-validation studies challenging. K2- and K3-EDTA could potentially influence qPCR outcomes, underscoring the need for standardized protocols. A consensus-based methodology could improve reproducibility, enhancing miRNA-based biomarker utility in adrenocortical tumor diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Cortex NeoplasmsCirculating MicroRNAMicroRNAsBiomarkers, TumorHumansFemaleMaleMiddle AgedAdultAgedReal-Time Polymerase Chain Reaction

Stichwörter der Autor:innen

EDTAadrenocortical carcinomadPCRmicroRNAqPCR

Substanzen

Circulating MicroRNAMicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

ORCID-Profile: Bálint Vékony, Attila Patócs, Peter Igaz

Zitieren

APA

Vékony, B., Nyirő, G., Butz, H., Szeredás, B. K., Tóth, V., Ferdinandy, P., Patócs, A., & Igaz, P. (2025). Challenges in circulating miRNA analysis in adrenocortical tumors. Endocrine-Related Cancer. https://doi.org/10.1530/erc-25-0045

Vancouver

Vékony B, Nyirő G, Butz H, Szeredás BK, Tóth V, Ferdinandy P, et al. Challenges in circulating miRNA analysis in adrenocortical tumors. Endocrine-Related Cancer. 2025. doi:10.1530/erc-25-0045

BibTeX
@article{Vkony2025,
  author = {Vékony, Bálint and Nyirő, Gábor and Butz, Henriett and Szeredás, Bálint Kende and Tóth, Viktória and Ferdinandy, Peter and Patócs, Attila and Igaz, Peter},
  title = {Challenges in circulating miRNA analysis in adrenocortical tumors},
  journal = {Endocrine-Related Cancer},
  year = {2025},
  doi = {10.1530/erc-25-0045}
}
Kostenlos starten →